These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


97 related items for PubMed ID: 7249257

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Oxygen consumption and oxygen diffusion properties of multicellular spheroids from two different cell lines.
    Mueller-Klieser WF, Sutherland RM.
    Adv Exp Med Biol; 1984; 180():311-21. PubMed ID: 6534108
    [Abstract] [Full Text] [Related]

  • 9. Sensitization of cells to ionizing radiation by chlorin e6Na.
    Hosoi Y, Kawamura M, Ido T, Takai Y, Ishii K, Nemoto K, Ono T, Kimura S, Sakamoto K.
    Radiat Oncol Investig; 1998; 6(4):151-6. PubMed ID: 9727873
    [Abstract] [Full Text] [Related]

  • 10. Oxygen enhancement ratio in V79 spheroids.
    Durand RE.
    Radiat Res; 1983 Nov; 96(2):322-34. PubMed ID: 6647761
    [Abstract] [Full Text] [Related]

  • 11. Cure, regression and cell survival: a comparison of common radiobiological endpoints using an in vitro tumour model.
    Durand RE.
    Br J Radiol; 1975 Jul; 48(571):556-71. PubMed ID: 1148588
    [Abstract] [Full Text] [Related]

  • 12. Radiation sensitivity modification by chemotherapeutic agents.
    Hetzel FW, Brown M, Kaufman N, Bicher HI.
    Cancer Clin Trials; 1981 Jul; 4(2):177-82. PubMed ID: 7249254
    [Abstract] [Full Text] [Related]

  • 13. Hypoxic cell radiosensitizers--chemical aspects and in vitro models.
    Wardman P.
    Strahlentherapie Sonderb; 1978 Jul; 75():20-6. PubMed ID: 555049
    [No Abstract] [Full Text] [Related]

  • 14. In situ oxygen consumption rates of cells in V-79 multicellular spheroids during growth.
    Freyer JP, Tustanoff E, Franko AJ, Sutherland RM.
    J Cell Physiol; 1984 Jan; 118(1):53-61. PubMed ID: 6690452
    [Abstract] [Full Text] [Related]

  • 15. Multicell spheroid response to drugs predicted with the comet assay.
    Olive PL, Banáth JP.
    Cancer Res; 1997 Dec 15; 57(24):5528-33. PubMed ID: 9407963
    [Abstract] [Full Text] [Related]

  • 16. Adriamycin: a possible indirect radiosensitizer of hypoxic tumor cells.
    Durand RE.
    Radiology; 1976 Apr 15; 119(1):217-22. PubMed ID: 1257446
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In vitro and in vivo radiation sensitization by the halogenated pyrimidine 5-chloro-2'-deoxycytidine.
    Russell KJ, Rice GC, Brown JM.
    Cancer Res; 1986 Jun 15; 46(6):2883-7. PubMed ID: 3698014
    [Abstract] [Full Text] [Related]

  • 19. Combination adriamycin/misonidazole toxicity in V79 spheroids.
    Durand RE, Brown SM.
    Int J Radiat Oncol Biol Phys; 1982 Jun 15; 8(3-4):603-5. PubMed ID: 7107380
    [Abstract] [Full Text] [Related]

  • 20. Elimination of hypoxic protection by 5-thio-D-glucose in multicell spheroids.
    Song CW, Clement JJ, Levitt SH.
    Cancer Res; 1978 Dec 15; 38(12):4499-503. PubMed ID: 719634
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.